ANI Pharmaceuticals, Inc.ANIPNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$47.06M
↑ 549% above average
Average (9y)
$-10.49M
Historical baseline
Range
High:$100.45M
Low:$-121.59M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $47.06M | -53.1% |
| 2023 | $100.45M | +310.8% |
| 2022 | $-47.66M | -134.6% |
| 2021 | $-20.32M | +61.7% |
| 2020 | $-53.05M | -393.4% |
| 2019 | $18.08M | -67.8% |
| 2018 | $56.16M | +181.9% |
| 2017 | $-68.57M | +43.6% |
| 2016 | $-121.59M | -688.6% |
| 2015 | $-15.42M | - |